Keith Johnson - Related publications

Affiliations: 
2005- Linguistics University of California, Berkeley, Berkeley, CA 
Area:
Phonetics
Website:
http://www.linguistics.berkeley.edu/~kjohnson/
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2019 Ottoy J, Niemantsverdriet E, Verhaeghe J, De Roeck E, Struyfs H, Somers C, Wyffels L, Ceyssens S, Van Mossevelde S, Van den Bossche T, Van Broeckhoven C, Ribbens A, Bjerke M, Stroobants S, Engelborghs S, et al. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and F-FDG-PET imaging. Neuroimage. Clinical. 22: 101771. PMID 30927601 DOI: 10.1016/j.nicl.2019.101771   
2019 Cho H, Choi JY, Lee HS, Lee JH, Ryu YH, Lee MS, Jack CR, Lyoo CH. Progressive tau accumulation in Alzheimer's disease: two-year follow-up study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30926651 DOI: 10.2967/jnumed.118.221697   
2019 Franzmeier N, Rubinski A, Neitzel J, Kim Y, Damm A, Na DL, Kim HJ, Lyoo CH, Cho H, Finsterwalder S, Duering M, Seo SW, Ewers M, . Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease. Brain : a Journal of Neurology. PMID 30770704 DOI: 10.1093/brain/awz026   
2019 Wennberg AM, Whitwell JL, Tosakulwong N, Weigand SD, Murray ME, Machulda MM, Petrucelli L, Mielke MM, Jack CR, Knopman DS, Parisi JE, Petersen RC, Dickson DW, Josephs KA. The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals. Neurobiology of Aging. 77: 26-36. PMID 30776649 DOI: 10.1016/j.neurobiolaging.2019.01.008   
2019 Varatharajah Y, Ramanan VK, Iyer R, Vemuri P, . Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics. Scientific Reports. 9: 2235. PMID 30783207 DOI: 10.1038/s41598-019-38793-3   
2019 Guzmán-Martínez L, Tapia JP, Farías GA, González A, Estrella M, Maccioni RB. The Alz-tau Biomarker for Alzheimer's Disease: Study in a Caucasian Population. Journal of Alzheimer's Disease : Jad. PMID 30775977 DOI: 10.3233/JAD-180637   
2019 Wang M, Qin L, Tang B. MicroRNAs in Alzheimer's Disease. Frontiers in Genetics. 10: 153. PMID 30881384 DOI: 10.3389/fgene.2019.00153   
2019 Marizzoni M, Ferrari C, Macis A, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, ... , et al. Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 30958351 DOI: 10.3233/JAD-181016   
2019 Yan T, Wang Y, Weng Z, Du W, Liu T, Chen D, Li X, Wu J, Han Y. Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI. Journal of Alzheimer's Disease : Jad. PMID 30958352 DOI: 10.3233/JAD-181049   
2019 Bransby L, Lim YY, Ames D, Fowler C, Roberston J, Harrington K, Snyder PJ, Villemagne VL, Salvado O, Masters CL, Maruff P. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 1-10. PMID 30924399 DOI: 10.1080/13803395.2019.1593949   
2019 Adlimoghaddam A, Snow WM, Stortz G, Perez C, Djordjevic J, Goertzen AL, Ko JH, Albensi BC. Regional hypometabolism in the 3xTg mouse model of Alzheimer's disease. Neurobiology of Disease. PMID 30878533 DOI: 10.1016/j.nbd.2019.03.008   
2019 Manno FAM, Isla AG, Manno SHC, Ahmed I, Cheng SH, Barrios FA, Lau C. Early Stage Alterations in White Matter and Decreased Functional Interhemispheric Hippocampal Connectivity in the 3xTg Mouse Model of Alzheimer's Disease. Frontiers in Aging Neuroscience. 11: 39. PMID 30967770 DOI: 10.3389/fnagi.2019.00039   
2019 Plagman A, Hoscheidt S, McLimans KE, Klinedinst B, Pappas C, Anantharam V, Kanthasamy A, Willette AA, . Cholecystokinin and Alzheimer's disease: a biomarker of metabolic function, neural integrity, and cognitive performance. Neurobiology of Aging. 76: 201-207. PMID 30739077 DOI: 10.1016/j.neurobiolaging.2019.01.002   
2019 Martinez B, Peplow PV. Amelioration of Alzheimer's disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer's disease. Neural Regeneration Research. 14: 1158-1176. PMID 30804241 DOI: 10.4103/1673-5374.251192   
2019 Mullane K, Williams M. The de-Alzheimerization of age-related dementias: implications for drug targets and approaches to effective therapeutics. Current Opinion in Pharmacology. PMID 30795894 DOI: 10.1016/j.coph.2019.01.004   
2019 Hwang J, Jeong JH, Yoon SJ, Park KW, Kim EJ, Yoon B, Jang JW, Kim HJ, Hong JY, Lee JM, Park H, Kang JH, Choi YH, Park G, Hong J, et al. Clinical and Biomarker Characteristics According to Clinical Spectrum of Alzheimer's Disease (AD) in the Validation Cohort of Korean Brain Aging Study for the Early Diagnosis and Prediction of AD. Journal of Clinical Medicine. 8. PMID 30862124 DOI: 10.3390/jcm8030341   
2019 Oliver DMA, Reddy PH. Molecular Basis of Alzheimer's Disease: Focus on Mitochondria. Journal of Alzheimer's Disease : Jad. PMID 30932888 DOI: 10.3233/JAD-190048   
2019 Mullane K, Williams M. Preclinical Models of Alzheimer's Disease: Relevance and Translational Validity. Current Protocols in Pharmacology. e57. PMID 30802363 DOI: 10.1002/cpph.57   
2019 Marston KJ, Brown BM, Rainey-Smith SR, Peiffer JJ. Resistance Exercise-Induced Responses in Physiological Factors Linked with Cognitive Health. Journal of Alzheimer's Disease : Jad. PMID 30776004 DOI: 10.3233/JAD-181079   
2019 Li WW, Shen YY, Tian DY, Bu XL, Zeng F, Liu YH, Chen Y, Yao XQ, Li HY, Chen DW, Zhou FY, Yang H, Li QM, Bao WQ, Guan YH, et al. Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 30958377 DOI: 10.3233/JAD-190056   
2019 Power R, Prado-Cabrero A, Mulcahy R, Howard A, Nolan JM. The Role of Nutrition for the Aging Population: Implications for Cognition and Alzheimer's Disease. Annual Review of Food Science and Technology. 10: 619-639. PMID 30908950 DOI: 10.1146/annurev-food-030216-030125   
2019 Funaki K, Nakajima S, Noda Y, Wake T, Ito D, Yamagata B, Yoshizaki T, Kameyama M, Nakahara T, Murakami K, Jinzaki M, Mimura M, Tabuchi H. Can we predict amyloid deposition by objective cognition and regional cerebral blood flow in patients with subjective cognitive decline? Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society. PMID 30688000 DOI: 10.1111/psyg.12397   
2019 Bubu OM, Pirraglia E, Andrade AG, Sharma RA, Gimenez-Badia S, Umasabor-Bubu OQ, Hogan MM, Shim AM, Mukhtar F, Sharma N, Mbah AK, Seixas AA, Kam K, Zizi F, Borenstein AR, ... , et al. Obstructive Sleep Apnea and Longitudinal Alzheimer's disease biomarker changes. Sleep. PMID 30794315 DOI: 10.1093/sleep/zsz048   
2019 Goudey B, Fung BJ, Schieber C, Faux NG, , . A blood-based signature of cerebrospinal fluid Aβ status. Scientific Reports. 9: 4163. PMID 30853713 DOI: 10.1038/s41598-018-37149-7   
2019 Angehrn Z, Nordon C, Turner A, Gove D, Karcher H, Keenan A, Neumann M, Sostar J, de Reydet de Vulpillieres F. Ethical and social implications of using predictive modeling for Alzheimer's disease prevention: a systematic literature review protocol. Bmj Open. 9: e026468. PMID 30833325 DOI: 10.1136/bmjopen-2018-026468   
2019 Mahalingam S, Chen MK. Neuroimaging in Dementias. Seminars in Neurology. 39: 188-199. PMID 30925612 DOI: 10.1055/s-0039-1678580   
2019 Zetterberg H, Burnham SC. Blood-based molecular biomarkers for Alzheimer's disease. Molecular Brain. 12: 26. PMID 30922367 DOI: 10.1186/s13041-019-0448-1   
2019 Sergeant N, Vingtdeux V, Eddarkaoui S, Gay M, Evrard C, Le Fur N, Laurent C, Caillierez R, Obriot H, Larchanché PE, Farce A, Coevoet M, Carato P, Kouach M, Descat A, et al. New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease. Neurobiology of Disease. PMID 30928644 DOI: 10.1016/j.nbd.2019.03.028   
2019 Forlenza OV, Radanovic M, Talib LL, Gattaz WF. Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial. The British Journal of Psychiatry : the Journal of Mental Science. 1-7. PMID 30947755 DOI: 10.1192/bjp.2019.76   
2019 Ma G, Liu M, Du K, Zhong X, Gong S, Jiao L, Wei M. Differential Expression of mRNAs in the Brain Tissues of Patients with Alzheimer's Disease Based on GEO Expression Profile and Its Clinical Significance. Biomed Research International. 2019: 8179145. PMID 30918899 DOI: 10.1155/2019/8179145   
2019 Deng L, Wang Y. [Progress in the study of the imaging genomics of Alzheimer's disease]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi. 36: 140-145. PMID 30887788 DOI: 10.7507/1001-5515.201805061   
2019 Kang SW, Jeon S, Yoo HS, Chung SJ, Lee PH, Sohn YH, Yun M, Evans AC, Ye BS. Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction. Neurology. PMID 30944239 DOI: 10.1212/WNL.0000000000007373   
2019 Brown EE, Shah P, Pollock BG, Gerretsen P, Graff-Guerrero A. Lead (Pb) in Alzheimer's Dementia: A Systematic Review of Human Case-control Studies. Current Alzheimer Research. PMID 30854970 DOI: 10.2174/1567205016666190311101445   
2019 D'Antonio F, Reeves S, Sheng Y, McLachlan E, de Lena C, Howard R, Bertrand J. Misidentification subtype of Alzheimer's disease psychosis predicts a faster cognitive decline. Cpt: Pharmacometrics & Systems Pharmacology. PMID 30779330 DOI: 10.1002/psp4.12389   
2019 Gu L, Zhang ZJ. Exploring structural and functional brain changes in mild cognitive impairment: a whole brain ALE meta-analysis for multimodal MRI. Acs Chemical Neuroscience. PMID 30808171 DOI: 10.1021/acschemneuro.9b00045   
2019 Armstrong NM, Huang CW, Williams OA, Bilgel M, An Y, Doshi J, Erus G, Davatzikos C, Wong DF, Ferrucci L, Resnick SM. Sex differences in the association between amyloid and longitudinal brain volume change in cognitively normal older adults. Neuroimage. Clinical. 22: 101769. PMID 30927602 DOI: 10.1016/j.nicl.2019.101769   
2019 Iadecola C, Gottesman RF. Neurovascular and Cognitive Dysfunction in Hypertension. Circulation Research. 124: 1025-1044. PMID 30920929 DOI: 10.1161/CIRCRESAHA.118.313260   
2019 Sato K, Mano T, Ihara R, Suzuki K, Tomita N, Arai H, Ishii K, Senda M, Ito K, Ikeuchi T, Kuwano R, Matsuda H, Iwatsubo T, Toda T, Iwata A, , et al. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative. Journal of Alzheimer's Disease : Jad. PMID 30814351 DOI: 10.3233/JAD-181115   
2019 Santos JRF, Bauer C, Schuchhardt J, Wedekind D, Waniek K, Lachmann I, Wiltfang J, Vogelgsang J. Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 30767082 DOI: 10.1007/s00702-019-01982-5   
2019 Liu E, Zhou Q, Xie AJ, Li M, Zhang S, Huang H, Liuyang Z, Wang Y, Liu B, Li X, Sun D, Wei Y, Wang X, Wang Q, Ke D, et al. Enriched gestation activates the IGF pathway to evoke embryo-adult benefits to prevent Alzheimer's disease. Translational Neurodegeneration. 8: 8. PMID 30867903 DOI: 10.1186/s40035-019-0149-9   
2019 Cho SJ, Lim HJ, Jo C, Park MH, Han C, Koh YH. Plasma ATG5 is increased in Alzheimer's disease. Scientific Reports. 9: 4741. PMID 30894637 DOI: 10.1038/s41598-019-41347-2   
2019 Chiquita S, Ribeiro M, Castelhano J, Oliveira F, Sereno J, Batista M, Abrunhosa A, Rodrigues-Neves AC, Carecho R, Baptista F, Gomes C, Moreira PI, Ambrósio AF, Castelo-Branco M. A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss. Human Molecular Genetics. PMID 30816415 DOI: 10.1093/hmg/ddz045   
2019 Mansour Y, Blackburn K, González-González LO, Calderón-Garcidueñas L, Kulesza RJ. Auditory Brainstem Dysfunction, Non-Invasive Biomarkers for Early Diagnosis and Monitoring of Alzheimer's Disease in Young Urban Residents Exposed to Air Pollution. Journal of Alzheimer's Disease : Jad. 67: 1147-1155. PMID 30741678 DOI: 10.3233/JAD-181186   
2019 Mandal PK, Shukla D, Tripathi M, Ersland L. Cognitive Improvement with Glutathione Supplement in Alzheimer's Disease: A Way Forward. Journal of Alzheimer's Disease : Jad. PMID 30776003 DOI: 10.3233/JAD-181054   
2019 Devanarayan P, Devanarayan V, Llano DA, . Identification of a Simple and Novel Cut-Point Based Cerebrospinal Fluid and MRI Signature for Predicting Alzheimer's Disease Progression that Reinforces the 2018 NIA-AA Research Framework. Journal of Alzheimer's Disease : Jad. PMID 30775985 DOI: 10.3233/JAD-180905   
2019 Wilson H, Pagano G, Politis M. Dementia spectrum disorders: lessons learnt from decades with PET research. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 30762136 DOI: 10.1007/s00702-019-01975-4   
2019 Serrano-Pozo A, Growdon JH. Is Alzheimer's Disease Risk Modifiable? Journal of Alzheimer's Disease : Jad. 67: 795-819. PMID 30776012 DOI: 10.3233/JAD181028   
2019 El Hajj H, Savage JC, Bisht K, Parent M, Vallières L, Rivest S, Tremblay MÈ. Ultrastructural evidence of microglial heterogeneity in Alzheimer's disease amyloid pathology. Journal of Neuroinflammation. 16: 87. PMID 30992040 DOI: 10.1186/s12974-019-1473-9   
2019 Deshpande P, Gogia N, Singh A. Exploring the efficacy of natural products in alleviating Alzheimer's disease. Neural Regeneration Research. 14: 1321-1329. PMID 30964049 DOI: 10.4103/1673-5374.253509   
2019 Bazzari FH, Abdallah DM, El-Abhar HS. Pharmacological Interventions to Attenuate Alzheimer's Disease Progression: The Story So Far. Current Alzheimer Research. PMID 30827243 DOI: 10.2174/1567205016666190301111120